{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T02:08:36Z","timestamp":1792030116914,"version":"4.4.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.bbrc.2013.02.125","type":"journal-article","created":{"date-parts":[[2013,3,26]],"date-time":"2013-03-26T18:18:08Z","timestamp":1364321888000},"page":"322-327","source":"Crossref","is-referenced-by-count":25,"title":["3-Bromopyruvate: A novel antifungal agent against the human pathogen Cryptococcus neoformans"],"prefix":"10.1016","volume":"434","author":[{"given":"Mariusz","family":"Dyl\u0105g","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawe\u0142","family":"Lis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Nied\u017awiecka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young H.","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter L.","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Goffeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanis\u0142aw","family":"U\u0142aszewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2013.02.125_b0005","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ccm.2009.02.006","article-title":"Cryptococcosis: an emerging respiratory mycosis","volume":"30","author":"Huston","year":"2009","journal-title":"Clin. Chest Med."},{"key":"10.1016\/j.bbrc.2013.02.125_b0010","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s11046-011-9473-z","article-title":"Ten challenges on Cryptococcus and cryptococcosis","volume":"173","author":"Del Poeta","year":"2012","journal-title":"Mycopathologia"},{"key":"10.1016\/j.bbrc.2013.02.125_b0015","doi-asserted-by":"crossref","first-page":"e1001316","DOI":"10.1371\/journal.pmed.1001316","article-title":"Cryptococcal meningitis treatment strategies in resource-limited settings: a cost-effectiveness analysis","volume":"9","author":"Rajasingham","year":"2012","journal-title":"PLOS Med."},{"key":"10.1016\/j.bbrc.2013.02.125_b0020","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/QAD.0b013e328322ffac","article-title":"Estimation of the current global burden of cryptococcal meningitis among persons living with HIV\/AIDS","volume":"23","author":"Park","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.bbrc.2013.02.125_b0025","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.riam.2009.06.003","article-title":"Amphotericin B: side effects and toxicity","volume":"26","author":"Laniado-Laborin","year":"2009","journal-title":"Rev. Iberoam. Micol."},{"key":"10.1016\/j.bbrc.2013.02.125_b0030","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/cid\/cir745","article-title":"Comparison of the early fungicidal activity of high-dose fluconazole, voriconazole, and flucytosine as second-line drugs given in combination with amphotericin B for the treatment of HIV-associated cryptococcal meningitis","volume":"54","author":"Loyse","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.bbrc.2013.02.125_b0035","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/jac\/46.2.171","article-title":"Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions","volume":"46","author":"Vermes","year":"2000","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.bbrc.2013.02.125_b0040","doi-asserted-by":"crossref","first-page":"e1000848","DOI":"10.1371\/journal.ppat.1000848","article-title":"Cryptococcus neoformans overcomes stress of azole drugs by formation of disomy in specific multiple chromosomes","volume":"6","author":"Sionov","year":"2010","journal-title":"PLOS Pathog."},{"key":"10.1016\/j.bbrc.2013.02.125_b0045","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1128\/CMR.00051-08","article-title":"Efflux-mediated antifungal drug resistance","volume":"22","author":"Cannon","year":"2009","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.bbrc.2013.02.125_b0050","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0304-3835(01)00667-X","article-title":"Glucose catabolism in the rabbit VX2 tumor model for liver cancer: characterization and targeting hexokinase","volume":"173","author":"Ko","year":"2001","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbrc.2013.02.125_b0055","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.bbrc.2004.09.047","article-title":"Advanced cancers: eradication in all cases using 3-bromopyruvate therapy to deplete ATP","volume":"5","author":"Ko","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2013.02.125_b0060","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s10637-008-9145-0","article-title":"Specificity of the anti-glycolytic activity of 3-bromopyruvate confirmed by FDG uptake in a rat model of breast cancer","volume":"27","author":"Buijs","year":"2009","journal-title":"Invest. New Drug"},{"key":"10.1016\/j.bbrc.2013.02.125_b0065","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.bbabio.2010.03.025","article-title":"The pivotal roles of mitochondria in cancer: warburg and beyond and encouraging prospects for effective therapies","volume":"1797","author":"Mathupala","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbrc.2013.02.125_b0070","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.trsl.2011.08.008","article-title":"Systemic administration of 3-bromopyruvate in treating disseminated aggressive lymphoma","volume":"159","author":"Schaefer","year":"2012","journal-title":"Transl. Res."},{"key":"10.1016\/j.bbrc.2013.02.125_b0075","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s10863-012-9421-8","article-title":"Transport and cytotoxicity of the anticancer drug 3-bromopyruvate in the yeast Saccharomyces cerevisiae","volume":"44","author":"Lis","year":"2012","journal-title":"J. Bioenerg. Biomembr."},{"key":"10.1016\/j.bbrc.2013.02.125_b0080","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/452541a","article-title":"Drug resistance: the fight against fungi","volume":"452","author":"Goffeau","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2013.02.125_b0085","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1146\/annurev-micro-092611-150111","article-title":"Yeast ATP-binding cassette transporters conferring multidrug resistance","volume":"66","author":"Prasad","year":"2012","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.bbrc.2013.02.125_b0090","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00277-008-0622-5","article-title":"Treatment of invasive fungal infections in cancer patients \u2013 recommendations of the infectious diseases working part (AGIHO) of the German society of hematology and oncology (DGHO)","volume":"88","author":"B\u00f6hme","year":"2009","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.bbrc.2013.02.125_b0095","series-title":"Methods in Yeast Genetics 2005: A Cold Spring Harbor Laboratory Course Manual","author":"Amberg","year":"2005"},{"key":"10.1016\/j.bbrc.2013.02.125_b0100","unstructured":"P.A. Wayne, National Committee for Clinical Laboratory Standards, Reference Methods for Broth Dilution Antifungal Susceptibility Testing of Yeast, Approved Standard M27\u2013A2, NCCLS, 2002."},{"key":"10.1016\/j.bbrc.2013.02.125_b0105","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1080\/13693780701549364","article-title":"Evaluation of microdilution and disk diffusion methods for antifungal susceptibility testing of dermatophytes","volume":"45","author":"Singh","year":"2007","journal-title":"Med. Mycol."},{"key":"10.1016\/j.bbrc.2013.02.125_b0110","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1128\/JB.181.8.2620-2623.1999","article-title":"The lactate-proton symport of Saccharomyces cerevisiae is encoded by Jen1","volume":"181","author":"Casal","year":"1999","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.bbrc.2013.02.125_b0115","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/carcin\/bgi222","article-title":"Glutathione depletion by buthionine sulfoximine induces DNA deletions in mice","volume":"27","author":"Reliene","year":"2006","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bbrc.2013.02.125_b0120","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/j.1567-1364.2007.00245.x","article-title":"Evolution of the carboxylate Jen transporters in fungi","volume":"7","author":"Lodi","year":"2007","journal-title":"FEMS Yeast Res."},{"key":"10.1016\/j.bbrc.2013.02.125_b0125","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1111\/j.1574-6976.2008.00128.x","article-title":"Transport of carboxylic acids in yeast","volume":"32","author":"Casal","year":"2008","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.bbrc.2013.02.125_b0130","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/1471-2148-9-195","article-title":"A fungal phylogeny based on 82 complete genomes using the composition vector method","volume":"9","author":"Wang","year":"2009","journal-title":"BMC Evol. Biol."},{"key":"10.1016\/j.bbrc.2013.02.125_b0135","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1126\/science.1103773","article-title":"The genome of the basidiomycetous yeast and human pathogen Cryptococcus neoformans","volume":"307","author":"Loftus","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2013.02.125_b0140","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1373\/49.3.487","article-title":"Cerebrospinal fluid lactate and pyruvate concentrations and their ratio in children: age-related reference intervals","volume":"49","author":"Benoist","year":"2003","journal-title":"Clin. Chem."},{"key":"10.1016\/j.bbrc.2013.02.125_b0145","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1128\/EC.05273-11","article-title":"Adaptation of Cryptococcus neoformans to mammalian hosts: integrated regulation of metabolism and virulence","volume":"11","author":"Kronstad","year":"2012","journal-title":"Eucaryot. Cell"},{"key":"10.1016\/j.bbrc.2013.02.125_b0150","first-page":"826","article-title":"Report membrane transport of lactic acid in the filamentous fungus Rhizopus","volume":"15","author":"Skory","year":"2010","journal-title":"KKU Res. J."},{"key":"10.1016\/j.bbrc.2013.02.125_b0155","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1158\/1940-6207.CAPR-11-0338","article-title":"Aerosolized 3-bromopyruvate inhibits lung tumorigenesis without causing liver toxicity","volume":"5","author":"Zhang","year":"2012","journal-title":"Cancer Prev. Res."},{"key":"10.1016\/j.bbrc.2013.02.125_b0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-2911(04)49001-8","article-title":"Glutathione, altruistic metabolite in fungi","volume":"49","author":"Pocsi","year":"2004","journal-title":"Adv. Microb. Physiol."},{"key":"10.1016\/j.bbrc.2013.02.125_b0165","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2174\/1389200043489199","article-title":"The MRP-related and BCRP\/ABCG2 multidrug resistance proteins: biology, substrate and regulation","volume":"5","author":"Haimeur","year":"2004","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.bbrc.2013.02.125_b0170","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.etap.2008.02.006","article-title":"Glutathione dependent interaction of heavy metal compounds with multidrug resistance proteins MRP1 and MRP2","volume":"26","author":"Wortelboer","year":"2008","journal-title":"Environ. Toxicol. Pharm."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X13004828?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X13004828?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,24]],"date-time":"2020-07-24T11:04:39Z","timestamp":1595588679000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X13004828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S0006291X13004828"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2013.02.125","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}